News
Novo Holdings, a global life sciences investor, today announced its investment in SCHOTT Poonawalla, India's leading provider ...
Novonesis Co-Hosts Partnering Day 2025 in Singapore to Advance Biosolutions for a Sustainable Future
Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...
A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...
With a late-stage trial win for its Norditropin heir in hand, Novo Nordisk is making good on plans to boost its profile in ...
The best metric is not weight, but a particularly toxic kind of fat.
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best pharma stocks to invest in now amid the domestic ...
The REAL8 basket study showed Sogroya (somapacitan) was non-inferior to Norditropin (somatropin) in improving yearly growth ...
The Tata-Cornell Institute project aims to strengthen Indian food value chains for climate resilience and nutritious diets.
14hon MSN
If people could design very efficient enzymes from scratch, you could solve many important problems,” said UCSB chemistry ...
The world's first commercial-scale e-methanol plant began operations in Denmark on Tuesday, with shipping giant Maersk set to ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results